Equine Influenza Vaccine Market
1 Study Coverage
1.1 Equine Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Equine Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Equine Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home
1.3.3 Pet Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Equine Influenza Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Equine Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Equine Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Equine Influenza Vaccine Sales by Region
2.4.1 Global Equine Influenza Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Equine Influenza Vaccine by Region (2023-2028)
2.5 Global Equine Influenza Vaccine Revenue by Region
2.5.1 Global Equine Influenza Vaccine Revenue by Region (2017-2022)
2.5.2 Global Equine Influenza Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Equine Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Equine Influenza Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Equine Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Equine Influenza Vaccine in 2021
3.2 Global Equine Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Equine Influenza Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Equine Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Equine Influenza Vaccine Revenue in 2021
3.3 Global Equine Influenza Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Equine Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Equine Influenza Vaccine Sales by Type
4.1.1 Global Equine Influenza Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Equine Influenza Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Equine Influenza Vaccine Revenue by Type
4.2.1 Global Equine Influenza Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Equine Influenza Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Equine Influenza Vaccine Price by Type
4.3.1 Global Equine Influenza Vaccine Price by Type (2017-2022)
4.3.2 Global Equine Influenza Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Equine Influenza Vaccine Sales by Application
5.1.1 Global Equine Influenza Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Equine Influenza Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Equine Influenza Vaccine Revenue by Application
5.2.1 Global Equine Influenza Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Equine Influenza Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Equine Influenza Vaccine Price by Application
5.3.1 Global Equine Influenza Vaccine Price by Application (2017-2022)
5.3.2 Global Equine Influenza Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Equine Influenza Vaccine Market Size by Type
6.1.1 North America Equine Influenza Vaccine Sales by Type (2017-2028)
6.1.2 North America Equine Influenza Vaccine Revenue by Type (2017-2028)
6.2 North America Equine Influenza Vaccine Market Size by Application
6.2.1 North America Equine Influenza Vaccine Sales by Application (2017-2028)
6.2.2 North America Equine Influenza Vaccine Revenue by Application (2017-2028)
6.3 North America Equine Influenza Vaccine Market Size by Country
6.3.1 North America Equine Influenza Vaccine Sales by Country (2017-2028)
6.3.2 North America Equine Influenza Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Equine Influenza Vaccine Market Size by Type
7.1.1 Europe Equine Influenza Vaccine Sales by Type (2017-2028)
7.1.2 Europe Equine Influenza Vaccine Revenue by Type (2017-2028)
7.2 Europe Equine Influenza Vaccine Market Size by Application
7.2.1 Europe Equine Influenza Vaccine Sales by Application (2017-2028)
7.2.2 Europe Equine Influenza Vaccine Revenue by Application (2017-2028)
7.3 Europe Equine Influenza Vaccine Market Size by Country
7.3.1 Europe Equine Influenza Vaccine Sales by Country (2017-2028)
7.3.2 Europe Equine Influenza Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Equine Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Equine Influenza Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Equine Influenza Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Equine Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Equine Influenza Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Equine Influenza Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Equine Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Equine Influenza Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Equine Influenza Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Equine Influenza Vaccine Market Size by Type
9.1.1 Latin America Equine Influenza Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Equine Influenza Vaccine Revenue by Type (2017-2028)
9.2 Latin America Equine Influenza Vaccine Market Size by Application
9.2.1 Latin America Equine Influenza Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Equine Influenza Vaccine Revenue by Application (2017-2028)
9.3 Latin America Equine Influenza Vaccine Market Size by Country
9.3.1 Latin America Equine Influenza Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Equine Influenza Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Equine Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Equine Influenza Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Equine Influenza Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Equine Influenza Vaccine Market Size by Application
10.2.1 Middle East and Africa Equine Influenza Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Equine Influenza Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Equine Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Equine Influenza Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Equine Influenza Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Corporation Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Zoetis Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Corporation Information
11.2.2 Merck Animal Health Overview
11.2.3 Merck Animal Health Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Animal Health Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Animal Health Recent Developments
11.3 Boehringer Ingelheim Vetmedica
11.3.1 Boehringer Ingelheim Vetmedica Corporation Information
11.3.2 Boehringer Ingelheim Vetmedica Overview
11.3.3 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Vetmedica Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Equine Influenza Vaccine Industry Chain Analysis
12.2 Equine Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Influenza Vaccine Production Mode & Process
12.4 Equine Influenza Vaccine Sales and Marketing
12.4.1 Equine Influenza Vaccine Sales Channels
12.4.2 Equine Influenza Vaccine Distributors
12.5 Equine Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Equine Influenza Vaccine Industry Trends
13.2 Equine Influenza Vaccine Market Drivers
13.3 Equine Influenza Vaccine Market Challenges
13.4 Equine Influenza Vaccine Market Restraints
14 Key Findings in The Global Equine Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Equine Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Liquid
Table 3. Major Manufacturers of Powder
Table 4. Global Equine Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Equine Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Equine Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
Table 7. Global Equine Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Equine Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
Table 9. Global Equine Influenza Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Equine Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Equine Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Equine Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Equine Influenza Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Equine Influenza Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Equine Influenza Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Equine Influenza Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Equine Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Equine Influenza Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Equine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Equine Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Influenza Vaccine as of 2021)
Table 21. Equine Influenza Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Equine Influenza Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Equine Influenza Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 26. Global Equine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 27. Global Equine Influenza Vaccine Sales Share by Type (2017-2022)
Table 28. Global Equine Influenza Vaccine Sales Share by Type (2023-2028)
Table 29. Global Equine Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Equine Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Equine Influenza Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Equine Influenza Vaccine Revenue Share by Type (2023-2028)
Table 33. Equine Influenza Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Equine Influenza Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 36. Global Equine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 37. Global Equine Influenza Vaccine Sales Share by Application (2017-2022)
Table 38. Global Equine Influenza Vaccine Sales Share by Application (2023-2028)
Table 39. Global Equine Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Equine Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Equine Influenza Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Equine Influenza Vaccine Revenue Share by Application (2023-2028)
Table 43. Equine Influenza Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Equine Influenza Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 46. North America Equine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 47. North America Equine Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Equine Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 50. North America Equine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 51. North America Equine Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Equine Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Equine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 54. North America Equine Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
Table 55. North America Equine Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Equine Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Equine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Equine Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Equine Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Equine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Equine Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Equine Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Equine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Equine Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Equine Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Equine Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Equine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Equine Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Equine Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Equine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Equine Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Equine Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Equine Influenza Vaccine Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Equine Influenza Vaccine Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Equine Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Equine Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Equine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Equine Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Equine Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Equine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Equine Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Equine Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Equine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Equine Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Equine Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Equine Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Equine Influenza Vaccine Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Equine Influenza Vaccine Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Equine Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Equine Influenza Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Equine Influenza Vaccine Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Equine Influenza Vaccine Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Equine Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Equine Influenza Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Equine Influenza Vaccine Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Equine Influenza Vaccine Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Equine Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Equine Influenza Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Major Businesses
Table 107. Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Zoetis Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Zoetis Recent Developments
Table 110. Merck Animal Health Corporation Information
Table 111. Merck Animal Health Description and Major Businesses
Table 112. Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Merck Animal Health Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merck Animal Health Recent Developments
Table 115. Boehringer Ingelheim Vetmedica Corporation Information
Table 116. Boehringer Ingelheim Vetmedica Description and Major Businesses
Table 117. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Boehringer Ingelheim Vetmedica Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Equine Influenza Vaccine Distributors List
Table 123. Equine Influenza Vaccine Customers List
Table 124. Equine Influenza Vaccine Market Trends
Table 125. Equine Influenza Vaccine Market Drivers
Table 126. Equine Influenza Vaccine Market Challenges
Table 127. Equine Influenza Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Influenza Vaccine Product Picture
Figure 3. Global Equine Influenza Vaccine Market Share by Type in 2021 & 2028
Figure 3. Liquid Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Equine Influenza Vaccine Market Share by Application in 2021 & 2028
Figure 6. Home
Figure 7. Pet Clinic
Figure 8. Others
Figure 9. Equine Influenza Vaccine Report Years Considered
Figure 10. Global Equine Influenza Vaccine Sales 2017-2028 (K Doses)
Figure 11. Global Equine Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Equine Influenza Vaccine Revenue 2017-2028 (US$ Million)
Figure 13. Global Equine Influenza Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Equine Influenza Vaccine Sales Market Share by Region (2017-2022)
Figure 15. Global Equine Influenza Vaccine Sales Market Share by Region (2023-2028)
Figure 16. North America Equine Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 17. North America Equine Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Equine Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 19. Europe Equine Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Equine Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 21. Asia-Pacific Equine Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Equine Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 23. Latin America Equine Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Equine Influenza Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 25. Middle East & Africa Equine Influenza Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Equine Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Equine Influenza Vaccine in the World: Market Share by Equine Influenza Vaccine Revenue in 2021
Figure 28. Global Equine Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 32. Global Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
Figure 33. North America Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 34. North America Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. North America Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 36. North America Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. North America Equine Influenza Vaccine Sales Share by Country (2017-2028)
Figure 38. North America Equine Influenza Vaccine Revenue Share by Country (2017-2028)
Figure 39. U.S. Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 42. Europe Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
Figure 43. Europe Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
Figure 45. Europe Equine Influenza Vaccine Sales Share by Country (2017-2028)
Figure 46. Europe Equine Influenza Vaccine Revenue Share by Country (2017-2028)
Figure 47. Germany Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. France Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Equine Influenza Vaccine Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Equine Influenza Vaccine Revenue Share by Region (2017-2028)
Figure 58. China Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. India Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Equine Influenza Vaccine Sales Share by Country (2017-2028)
Figure 73. Latin America Equine Influenza Vaccine Revenue Share by Country (2017-2028)
Figure 74. Mexico Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Equine Influenza Vaccine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Equine Influenza Vaccine Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Equine Influenza Vaccine Revenue Share by Country (2017-2028)
Figure 83. Turkey Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Equine Influenza Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. Equine Influenza Vaccine Value Chain
Figure 87. Equine Influenza Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
